Cover Image
市場調查報告書

醫療用植入的全球市場:各類型 (整形外科移植,心臟植入,支架,脊椎移植,神經刺激設備,人工植牙,豐胸手術,顏面植入),各材質 - 市場機會分析及產業預測

Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

出版商 Allied Market Research 商品編碼 370256
出版日期 內容資訊 英文 217 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
醫療用植入的全球市場:各類型 (整形外科移植,心臟植入,支架,脊椎移植,神經刺激設備,人工植牙,豐胸手術,顏面植入),各材質 - 市場機會分析及產業預測 Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials - Global Opportunity Analysis and Industry Forecast, 2014 - 2022
出版日期: 2016年08月01日 內容資訊: 英文 217 Pages
簡介

全球醫療用植入市場預測在2022年前將達到1億1,630萬美元的規模。慢性疾病的罹患率上升與迅速的高齡化維繫了市場的成長。與再加上醫療用植入技術的進步及認知度也有助於推動市場。

本報告提供全球醫療用植入市場相關調查,彙整市場各類型,各材料趨勢與各地區趨勢,2015∼2022年的預測,及加入此市場的主要企業簡介等資料。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義和範圍
  • 主要調查結果
  • 波特五力分析
  • 主要企業的定位
  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 機會

第4章 各產品市場

  • 概要
  • 整形外科移植
  • 心血管植入
  • 支架
  • 結構的心臟植入
  • 脊椎移植
  • 神經刺激設備
  • 眼科植入
  • 人工植牙
  • 顏面植入
  • 豐胸手術

第5章 各材料市場

  • 概要
  • 陶瓷生醫材料
  • 金屬製生醫材料
  • 聚合物生醫材料
  • 天然生醫材料

第6章 各地區市場

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 南美·中東·非洲

第7章 企業簡介

  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • Cardinal Health, Inc.
  • Conmed Corporation
  • Globus Medical, Inc.
  • Integra Lifesciences Holdings Corporation
  • Johnson & Johnson
  • LivaNova PLC
  • Medtronic plc
  • Nuvasive, Inc.
  • Smith & Nephew Plc
  • St. Jude Medical, Inc.
  • Institut Straumann AG.
  • Stryker Corporation
  • Wright Medical Group N.V.
  • Zimmer Biomet Holdings, Inc.

圖表

目錄
Product Code: LI 1671

Title: Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials (Metallic, Ceramic, Polymers, Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022.

Cover Image Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials. The world medical implants market is estimated to reach $116,300 million by 2022. The growth in the medical implants market is primarily attributed to the rising prevalence of chronic diseases coupled with the rapidly ageing population. Moreover, increased awareness and technological advancements in medical implants are further supporting the growth of the market. However, high implantation cost and lack of expertise are some of the factors restraining the growth of the medical implants market.

The world medical implants market is segmented on the basis of product type, material, and geography. Based on product type, the market is categorized into four major classes, namely, pacing devices, stents, structural cardiac implants, neurostimulators, spinal implants, ophthalmic implants, orthopedic implants, dental implants, breast implants, and facial implants. The orthopedic implants market was the highest revenue-generating segment in 2015, due to the stressful hyperactive lifestyle, unhealthy food habits, growing number of aging population and advancement in medical technologies. Neurostimulators is estimated to be the fastest growing segment, due to increasing prevalence of neurological diseases and rising ageing population. By material type, medical implants are segmented into metallic biomaterials, ceramic biomaterials, polymers biomaterials, and natural biomaterials. Based on geography, market is segmented into four major geographies, namely, North America, Europe, Asia-Pacific and LAMEA.

The report provides comprehensive analyses of the key players operating in the medical implants market such as Medtronic plc, Johnson and Johnson, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, Zimmer Biomet Holdings, Inc., LivaNova PLC, Stryker Incorporated, Smith and Nephew plc, Straumann Holding AG., Globus Medical, Inc., St. Jude Medical, Inc., Wright Medical Group N.V., NuVasive, Inc., Integra LifeSciences Holding Corporation, Cardinal Health, Inc., and Conmed Corporation.

KEY MARKET BENEFITS

  • The study provides an in-depth analysis of the world medical implants market with current trends and future estimations to elucidate the imminent investment pockets in the market.
  • The report provides a quantitative analysis from 2014 to 2022 that would enable the stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis of the world medical implants market, by product, helps in understanding the various types of devices used for the treatment of chronic diseases and other related cardiac conditions.
  • Competitive intelligence highlights the business practices followed by leading market players across various geographic regions.
  • SWOT analysis enables to study the internal environment of the leading companies for strategy formulation.

MEDICAL IMPLANTS MARKET SEGMENTS:

Theworldmedical implants market is segmented into product, biomaterial,and geography.

By Product

  • Orthopedic Implants
  • Reconstructive Joint Replacements
  • Knee Replacement Implants
  • Hip Replacement Implants
  • Extremities
  • Orthobiologics
  • Trauma & Craniomaxillofacial
  • Cardiovascular Implants
  • Pacing Devices
  • Cardiac Resynchronization Therapy Devices (CRTs)
  • CRT-P (CRT with pacemaker function)
  • CRT-D (CRT with pacemaker and ICD function)
  • Implantable Cardioverter Defibrillators (ICDs)
  • Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
  • Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
  • Stents
  • Coronary stents
  • Drug-eluting stents (DES)
  • Bare-metal coronary stents
  • Bioabsorbable stents
  • Peripheral stents
  • Iliac
  • Femoral-popliteal
  • Renal
  • Carotid
  • Stent-related Implants
  • Synthetic grafts
  • Vena cava filters
  • Structural Cardiac Implants
  • Mechanical heart valves
  • Implantable ventricular-assist devices
  • Left ventricular assist device (LVAD)
  • Rightventricular assist device (RVAD)
  • Biventricular assist device (BIVAD)
  • Spinal Implants
  • Interbody fusion devices
  • Thoracolumbar devices
  • Cervical fixation devices
  • Spinal electrical stimulation
  • Vertebral compression fracture (VCF) devices
  • Motion preservation devices
  • Neurostimulators
  • Deep brain stimulation (DBS)
  • Sacral nerve stimulation (SNS)
  • Vagus nerve stimulation (VNS)
  • Other neurostimulators
  • Ophthalmic Implants
  • Intraocular lens
  • Glaucoma implants
  • Dental Implants
  • Plate form dental implants
  • Root form dental implants
  • Breast Implants
  • Facial Implants

By Biomaterial

  • Metallic Biomaterials
  • Ceramic Biomaterials
  • Polymers Biomaterials
  • Natural Biomaterials

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East
    • Africa

Table of Contents

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key benefits
  • 1.3. Key market segments
  • 1.4. Research methodology
    • 1.4.1. Secondary research
    • 1.4.2. Primary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective
  • 2.2. Market beyond what to expect by 2027. ($Million)
    • 2.2.1. Moderate growth scenario
    • 2.2.2. Rapid growth scenario
    • 2.2.3. Diminishing growth scenario

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top investment pockets
    • 3.2.2. Top winning strategies
  • 3.3. Porters five forces analysis
    • 3.3.1. Bargaining power of suppliers
    • 3.3.2. Bargaining power of buyers
    • 3.3.3. Threat of new entrants
    • 3.3.4. High intensity of rivalry
    • 3.3.5. Threat of substitutes
  • 3.4. Top Player Positioning, 2015
  • 3.5. Market dynamics
    • 3.5.1. Drivers
      • 3.5.1.1. Growing elderly population and rise in prevalence of chronic diseases
      • 3.5.1.2. Technological advancements in the field of medical implants
      • 3.5.1.3. Global rise in acceptance of medical implants
      • 3.5.1.4. Improvement of healthcare infrastructure in developing countries
      • 3.5.1.5. Better insurance and reimbursement
      • 3.5.1.6. Increasing Government Focus on Funding R&D Initiatives
      • 3.5.1.7. Rising Number of FDA Approvals for Performing Clinical Trials to Benefit the Market
    • 3.5.2. Restraints
      • 3.5.2.1. High cost of treatment associated with medical implants
      • 3.5.2.2. Stringent approval process as these are highly specialized devices
    • 3.5.3. Opportunities
      • 3.5.3.1. Huge market opportunities in the APAC region and developing countries
      • 3.5.3.2. Increasing awareness amongst patients and increasing preference for a better quality of life
      • 3.5.3.3. Increase in development of minimally invasive and non-surgical procedures

CHAPTER 4: WORLD MEDICAL IMPLANTS MARKET, BY PRODUCT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Orthopedic implants
    • 4.2.1. Key market trend
    • 4.2.2. Key growth factors and opportunities
    • 4.2.3. Market size and forecast
    • 4.2.4. Reconstructive joint replacements
      • 4.2.4.1. Market size and forecast
      • 4.2.4.2. Knee replacement implants
        • 4.2.4.2.1. MARKET SIZE AND FORECAST
      • 4.2.4.3. Hip replacement implants
        • 4.2.4.3.1. MARKET SIZE AND FORECAST
      • 4.2.4.4. Extremities
        • 4.2.4.4.1. MARKET SIZE AND FORECAST
      • 4.2.4.5. Orthobiologics
        • 4.2.4.5.1. MARKET SIZE AND FORECAST
      • 4.2.4.6. Trauma & Craniomaxillofacial
        • 4.2.4.6.1. MARKET SIZE AND FORECAST
  • 4.3. Cardiovascular Implants
    • 4.3.1. Key market trends
    • 4.3.2. Key growth factors and opportunities
    • 4.3.3. Market size and forecast
    • 4.3.4. Pacing devices
      • 4.3.4.1. Market size and forecast
      • 4.3.4.2. Cardiac Resynchronization Therapy Devices (CRTs)
        • 4.3.4.2.1. MARKET SIZE AND FORECAST
        • 4.3.4.2.2. CRT-P (CRT WITH PACEMAKER FUNCTION)
        • 4.3.4.2.3. MARKET SIZE AND FORECAST
        • 4.3.4.2.4. CRT-D (CRT WITH PACEMAKER AND ICD FUNCTION)
        • 4.3.4.2.5. MARKET SIZE AND FORECAST
      • 4.3.4.3. Implantable Cardioverter Defibrillators (ICDs)
        • 4.3.4.3.1. MARKET SIZE AND FORECAST
        • 4.3.4.3.2. TRANS VENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (T-ICDS)
        • 4.3.4.3.3. MARKET SIZE AND FORECAST
        • 4.3.4.3.4. SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (S-ICDS)
        • 4.3.4.3.5. MARKET SIZE AND FORECAST
        • 4.3.4.3.6. IMPLANTABLE CARDIAC PACEMAKERS (ICPS)
        • 4.3.4.3.7. MARKET SIZE AND FORECAST
    • 4.3.5. Stents
      • 4.3.5.1. Key market trends
      • 4.3.5.2. Key growth factors and opportunities
      • 4.3.5.3. Market size and forecast
      • 4.3.5.4. Coronary Stents
        • 4.3.5.4.1. MARKET SIZE AND FORECAST
        • 4.3.5.4.2. DRUG-ELUTING STENTS (DES)
        • 4.3.5.4.3. MARKET SIZE AND FORECAST
        • 4.3.5.4.4. BARE-METAL CORONARY STENTS
        • 4.3.5.4.5. MARKET SIZE AND FORECAST
        • 4.3.5.4.6. BIOABSORBABLE STENTS
        • 4.3.5.4.7. MARKET SIZE AND FORECAST
      • 4.3.5.5. Peripheral stents
        • 4.3.5.5.1. MARKET SIZE AND FORECAST
        • 4.3.5.5.2. ILIAC STENT-GRAFTS
        • 4.3.5.5.3. MARKET SIZE AND FORECAST
        • 4.3.5.5.4. FEMORAL-POPLITEAL STENTS
        • 4.3.5.5.5. MARKET SIZE AND FORECAST
        • 4.3.5.5.6. RENAL & RELATED STENTS
        • 4.3.5.5.7. MARKET SIZE AND FORECAST
        • 4.3.5.5.8. CAROTID STENTS
        • 4.3.5.5.9. MARKET SIZE AND FORECAST
      • 4.3.5.6. Stent-related implants
        • 4.3.5.6.1. MARKET SIZE AND FORECAST
        • 4.3.5.6.2. SYNTHETIC GRAFTS
        • 4.3.5.6.3. MARKET SIZE AND FORECAST
        • 4.3.5.6.4. VENA CAVA FILTERS
        • 4.3.5.6.5. MARKET SIZE AND FORECAST
    • 4.3.6. Structural Cardiac Implants
      • 4.3.6.1. Market size and forecast
      • 4.3.6.2. Mechanical heart valves
        • 4.3.6.2.1. MARKET SIZE AND FORECAST
      • 4.3.6.3. Implantable Ventricular-assist devices
        • 4.3.6.3.1. MARKET SIZE AND FORECAST
      • 4.3.6.4. Left Ventricular Assist Device (LVAD)
        • 4.3.6.4.1. MARKET SIZE AND FORECAST
      • 4.3.6.5. Right Ventricular Assist Device (RVAD)
        • 4.3.6.5.1. MARKET SIZE AND FORECAST
      • 4.3.6.6. Biventricular Assist Device (BIVAD)
        • 4.3.6.6.1. MARKET SIZE AND FORECAST
  • 4.4. Spinal Implants
    • 4.4.1. Key market trends
    • 4.4.2. Key growth factors and opportunities
    • 4.4.3. Market size and forecast
    • 4.4.4. Interbody fusion devices
      • 4.4.4.1. Market size and forecast
    • 4.4.5. Thoracolumbar devices
      • 4.4.5.1. Market size and forecast
    • 4.4.6. Cervical fixation devices
      • 4.4.6.1. Market size and forecast
    • 4.4.7. Spinal electrical stimulation
      • 4.4.7.1. Market size and forecast
    • 4.4.8. Vertebral compression fracture (VCF) devices
      • 4.4.8.1. Market size and forecast
    • 4.4.9. Motion preservation devices
      • 4.4.9.1. Market size and forecast
  • 4.5. Neurostimulators
    • 4.5.1. Key market trends
    • 4.5.2. Key growth factors and opportunities
    • 4.5.3. Market size and forecast
    • 4.5.4. Deep brain stimulators
      • 4.5.4.1. Market size and forecast
    • 4.5.5. Sacral nerve stimulators
      • 4.5.5.1. Market size and forecast
    • 4.5.6. Spinal cord stimulators
      • 4.5.6.1. Market size and forecast
    • 4.5.7. Vagus nerve stimulators
      • 4.5.7.1. Market size and forecast
    • 4.5.8. Other Neurostimulators
      • 4.5.8.1. Market size and forecast
  • 4.6. Ophthalmic implants
    • 4.6.1. Key market trends
    • 4.6.2. Key growth factors and opportunities
    • 4.6.3. Market size and forecast
    • 4.6.4. Intraocular lens
      • 4.6.4.1. Market size and forecast
    • 4.6.5. Glaucoma implants
      • 4.6.5.1. Market size and forecast
  • 4.7. Dental implants
    • 4.7.1. Key market trends
    • 4.7.2. Key growth factors and opportunities
    • 4.7.3. Market size and forecast
    • 4.7.4. Plate-form dental implants
      • 4.7.4.1. Market size and forecast
    • 4.7.5. Root-form dental implants
      • 4.7.5.1. Market size and forecast
  • 4.8. Facial implants
    • 4.8.1. Key market trends
    • 4.8.2. Key growth factors and opportunities
    • 4.8.3. Market size and forecast
  • 4.9. Breast implants
    • 4.9.1. Key market trends
    • 4.9.2. Key growth factors and opportunities
    • 4.9.3. Market size and forecast

CHAPTER 5: WORLD MEDICAL IMPLANTS MARKET, BY BIOMATERIALS

  • 5.1. Overview
  • 5.2. Ceramics biomaterials
    • 5.2.1. Market size and forecast
  • 5.3. Metallic biomaterials
    • 5.3.1. Market size and forecast
  • 5.4. Polymers Biomaterials
    • 5.4.1. Market size and forecast
  • 5.5. Natural biomaterials
    • 5.5.1. Market size and forecast

CHAPTER 6: WORLD MEDICAL IMPLANTS MARKET, BY GEOGRAPHY

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. North America
    • 6.2.1. Key market trends
    • 6.2.2. Key growth factors and opportunities
    • 6.2.3. Market size and forecast
    • 6.2.4. U.S. market size and forecast
    • 6.2.5. Canada market size and forecast
    • 6.2.6. Mexico market size and forecast
  • 6.3. Europe
    • 6.3.1. Key market trends
    • 6.3.2. Key growth factors and opportunities
    • 6.3.3. Market size and forecast
    • 6.3.4. Germany market size and forecast
    • 6.3.5. France market size and forecast
    • 6.3.6. U.K. market size and forecast
    • 6.3.7. Rest of Europe market size and forecast
  • 6.4. Asia-Pacific
    • 6.4.1. Key market trends
    • 6.4.2. Key growth factors and opportunities
    • 6.4.3. Market size and forecast
    • 6.4.4. Japan market size and forecast
    • 6.4.5. China market size and forecast
    • 6.4.6. India market size and forecast
    • 6.4.7. Rest of Asia-Pacific market size and forecast
  • 6.5. LAMEA
    • 6.5.1. Key market trends
    • 6.5.2. Key growth factors and opportunities
    • 6.5.3. Market size and forecast
    • 6.5.4. Latin America market size and forecast
    • 6.5.5. Middle East market size and forecast
    • 6.5.6. Africa market size and forecast

CHAPTER 7: COMPANY PROFILES

  • 7.1. Abbott Laboratories
    • 7.1.1. Company overview
    • 7.1.2. Operating business segments
    • 7.1.3. Business performance
    • 7.1.4. Key strategic moves & developments
    • 7.1.5. SWOT analysis
  • 7.2. Biotronik SE & Co. KG
    • 7.2.1. Company overview
    • 7.2.2. Operating business segments
    • 7.2.3. Key strategic moves & developments
    • 7.2.4. SWOT analysis
  • 7.3. Boston Scientific Corporation
    • 7.3.1. Company overview
    • 7.3.2. Operating business segments
    • 7.3.3. Business performance
    • 7.3.4. Key strategic moves & developments
    • 7.3.5. SWOT analysis
  • 7.4. C. R. Bard, Inc.
    • 7.4.1. Company overview
    • 7.4.2. Operating business segments
    • 7.4.3. Business performance
    • 7.4.4. Key strategic moves & developments
    • 7.4.5. SWOT analysis
  • 7.5. Cardinal Health, Inc.
    • 7.5.1. Company overview
    • 7.5.2. Operating business segments
    • 7.5.3. Business performance
    • 7.5.4. Key strategic moves & developments
    • 7.5.5. SWOT analysis
  • 7.6. Conmed Corporation
    • 7.6.1. Company overview
    • 7.6.2. Operating business segments
    • 7.6.3. Business performance
    • 7.6.4. SWOT analysis
  • 7.7. Globus Medical, Inc.
    • 7.7.1. Company overview
    • 7.7.2. Operating business segments
    • 7.7.3. Business performance
    • 7.7.4. Key strategic moves & developments
    • 7.7.5. SWOT analysis
  • 7.8. Integra Lifesciences Holdings Corporation
    • 7.8.1. Company overview
    • 7.8.2. Operating business segments
    • 7.8.3. Business performance
    • 7.8.4. Key strategic moves & developments
    • 7.8.5. SWOT analysis
  • 7.9. Johnson & Johnson
    • 7.9.1. Company overview
    • 7.9.2. Operating business segments
    • 7.9.3. Business performance
    • 7.9.4. Key strategic moves & developments
    • 7.9.5. SWOT analysis
  • 7.10. LivaNova PLC
    • 7.10.1. Company overview
    • 7.10.2. Operating business segments
    • 7.10.3. Business performance
    • 7.10.4. Key strategic moves & developments
    • 7.10.5. SWOT analysis
  • 7.11. Medtronic plc
    • 7.11.1. Company overview
    • 7.11.2. Operating business segments
    • 7.11.3. Business performance
    • 7.11.4. Key strategic moves & developments
    • 7.11.5. SWOT analysis
  • 7.12. Nuvasive, Inc.
    • 7.12.1. Company overview
    • 7.12.2. Operating business segments
    • 7.12.3. Business performance
    • 7.12.4. Key strategic moves & developments
    • 7.12.5. SWOT analysis
  • 7.13. Smith & Nephew Plc
    • 7.13.1. Company overview
    • 7.13.2. Operating business segments
    • 7.13.3. Business performance
    • 7.13.4. Key strategic moves & developments
    • 7.13.5. SWOT analysis
  • 7.14. St. Jude Medical, Inc.
    • 7.14.1. Company overview
    • 7.14.2. Operating business segments
    • 7.14.3. Business performance
    • 7.14.4. Key strategic moves & developments
    • 7.14.5. SWOT analysis
  • 7.15. Institut Straumann AG.
    • 7.15.1. Company overview
    • 7.15.2. Straumann: Company Snapshot
    • 7.15.3. Business performance
    • 7.15.4. Key strategic moves & developments
    • 7.15.5. SWOT analysis
  • 7.16. Stryker Corporation
    • 7.16.1. Company overview
    • 7.16.2. Operating business segments
    • 7.16.3. Business performance
    • 7.16.4. Key strategic moves & developments
    • 7.16.5. SWOT analysis
  • 7.17. Wright Medical Group N.V.
    • 7.17.1. Company overview
    • 7.17.2. Operating business segments
    • 7.17.3. Business performance
    • 7.17.4. Key strategic moves & developments
    • 7.17.5. SWOT analysis
  • 7.18. Zimmer Biomet Holdings, Inc.
    • 7.18.1. Company overview
    • 7.18.2. Operating business segments
    • 7.18.3. Business performance
    • 7.18.4. Key strategic moves & developments
    • 7.18.5. SWOT analysis

List of Tables

  • TABLE 1: WORLD MEDICAL IMPLANTS MARKET, BY MODERATE GROWTH SCENARIO, 20222027 ($MILLION)
  • TABLE 2: WORLD MEDICAL IMPLANTS MARKET, BY RAPID GROWTH SCENARIO, 20222027 ($MILLION)
  • TABLE 3: WORLD MEDICAL IMPLANTS MARKET, BY DIMINISHING GROWTH SCENARIO, 20222027 ($MILLION)
  • TABLE 4: WORLD MEDICAL IMPLANTS MARKET, BY PRODUCT, 20142022 ($MILLION)
  • TABLE 5: WORLD MEDICAL IMPLANTS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
  • TABLE 6: TABLE 2 WORLD ORTHOPEDIC IMPLANT MARKET, BY TYPE ($MILLIONS), 2014-2022
  • TABLE 7: WORLD ORTHOPEDIC IMPLANT MARKET, BY GEOGRAPHY ($MILLIONS), 2014-2022
  • TABLE 8: RECONSTRUCTION JOINT REPLACEMENT MARKET BY TYPE, 20142022 ($MILLION)
  • TABLE 9: WORLD CARDIOVASCULAR IMPLANTS MARKET, BY TYPE, 20142022 ($MILLION)
  • TABLE 10: PACING DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
  • TABLE 11: CARDIAC RESYNCHRONIZATION THERAPY DEVICES, BY TYPE, 20142022 ($MILLION)
  • TABLE 12: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS BY TYPE, 20142022 ($MILLION)
  • TABLE 13: WORLD STENT MARKET, BY TYPE, 20142022 ($MILLION)
  • TABLE 14: WORLD CORONARY STENT MARKET, BY TYPE, 20142022 ($MILLION)
  • TABLE 15: WORLD PERIPHERAL STENT MARKET, BY TYPE, 20142022 ($MILLION)
  • TABLE 16: WORLD STENT -RELATED IMPLANTS MARKET, BY TYPE, 20142022 ($MILLION)
  • TABLE 17: WORLD STRUCTURAL CARDIAC IMPLANTS MARKET, BY TYPE, 20142022 ($MILLION)
  • TABLE 18: WORLD IMPLANTABLE VADS MARKET, BY TYPE, 20142022 ($MILLION)
  • TABLE 19: WORLD SPINAL IMPLANTS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
  • TABLE 20: WORLD SPINAL IMPLANTS MARKET, BY TYPE, 20142022 ($MILLION)
  • TABLE 21: WORLD NEUROSTIMULATOR IMPLANTS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
  • TABLE 22: WORLD NEUROSTIMULATOR IMPLANTS MARKET, BY TYPE, 20142022 ($MILLION)
  • TABLE 23: WORLD OPHTHALMIC IMPLANTS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
  • TABLE 24: WORLD OPHTHALMIC IMPLANTS MARKET, BY TYPE, 20142022 ($MILLION)
  • TABLE 25: WORLD DENTAL IMPLANTS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
  • TABLE 26: WORLD DENTAL IMPLANTS MARKET, BY TYPE, 20142022 ($MILLION)
  • TABLE 27: WORLD FACIAL IMPLANT MARKET, BY TYPE, 20142022 ($MILLION)
  • TABLE 28: WORLD FACIAL IMPLANT MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
  • TABLE 29: WORLD BREAST IMPLANT MARKET, BY TYPE, 20142022 ($MILLION)
  • TABLE 30: WORLD BREAST IMPLANT MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
  • TABLE 31: WORLD MEDICAL IMPLANT MARKET, BY MATERIAL, 20142022 ($MILLION)
  • TABLE 32: WORLD MEDICAL IMPLANT MATERIALS MARKET, BY GEOGRAPHY 20142022($MILLION)
  • TABLE 33: MEDICAL IMPLANTS MARKET, BY REGION, 2014-2022 ($MILLION)
  • TABLE 34: NORTH AMERICA MEDICAL IMPLANTS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
  • TABLE 35: NORTH AMERICA MEDICAL IMPLANTS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
  • TABLE 36: EUROPE MEDICAL IMPLANTS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
  • TABLE 37: EUROPE MEDICAL IMPLANTS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
  • TABLE 38: ASIA-PACIFIC MEDICAL IMPLANTS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
  • TABLE 39: ASIA-PACIFIC MEDICAL IMPLANTS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
  • TABLE 40: LAMEA MEDICAL IMPLANTS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
  • TABLE 41: LAMEA MEDICAL IMPLANTS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
  • TABLE 42: ABBOTT: COMPANY SNAPSHOT
  • TABLE 43: ABBOTT: OPERATING SEGMENTS
  • TABLE 44: BIOTRONIK- COMPANY SNAPSHOT
  • TABLE 45: BIOTRONIK: OPERATING SEGMENTS
  • TABLE 46: BOSTON SCIENTIFIC: COMPANY SNAPSHOT
  • TABLE 47: C. R. BARD- COMPANY SNAPSHOT
  • TABLE 48: CARDINAL HEALTH- COMPANY SNAPSHOT
  • TABLE 49: CARDINAL HEALTH: OPERATING SEGMENTS
  • TABLE 50: CONMED - COMPANY SNAPSHOT
  • TABLE 51: GLOBUS MEDICAL- COMPANY SNAPSHOT
  • TABLE 52: GLOBUS MEDICAL: PRODUCT CATEGORIES
  • TABLE 53: INTEGRA LIFESCIENCES - COMPANY SNAPSHOT
  • TABLE 54: J &J: COMPANY SNAPSHOT
  • TABLE 55: LIVANOVA: - COMPANY SNAPSHOT
  • TABLE 56: LIVANOVA: OPERATING SEGMENTS
  • TABLE 57: MEDTRONIC - COMPANY SNAPSHOT
  • TABLE 58: MEDTRONIC: OPERATING SEGMENTS
  • TABLE 59: NUVASIVE- COMPANY SNAPSHOT
  • TABLE 60: SMITH & NEPHEW - COMPANY SNAPSHOT
  • TABLE 61: ST. JUDE MEDICAL: COMPANY SNAPSHOT
  • TABLE 62: ST. JUDE MEDICAL: PRODUCT CATEGORIES
  • TABLE 63: STRYKER - COMPANY SNAPSHOT
  • TABLE 64: ZIMMER BIOMET- COMPANY SNAPSHOT

List of Figures

  • FIG. 1: IMPACT ANALYSIS OF MODERATE GROWTH SCENARIO (20222027)
  • FIG. 2: IMPACT ANALYSIS OF RAPID GROWTH SCENARIO (20222027)
  • FIG. 3: IMPACT ANALYSIS OF DIMINISHING GROWTH SCENARIO (2020-2027)
  • FIG. 4: TOP INVESTMENT POCKETS IN WORLD MEDICAL IMPLANTS MARKET
  • FIG. 5: TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (20142016)
  • FIG. 6: TOP WINNING STRATEGIES: NATURE & TYPE
  • FIG. 7: PORTERS FIVE FORCES ANALYSIS
  • FIG. 8: TOP PLAYER POSITIONING, 2015
  • FIG. 9: U.S. MEDICAL IMPLANTS MARKET, (20142022) ($MILLION)
  • FIG. 10: CANADA MEDICAL IMPLANTS MARKET, (20142022) ($MILLION)
  • FIG. 11: MEXICO MEDICAL IMPLANTS MARKET, (20142022) ($MILLION)
  • FIG. 12: GERMANY MEDICAL IMPLANTS MARKET, (20142022) ($MILLION)
  • FIG. 13: FRANCE MEDICAL IMPLANTS MARKET, (20142022) ($MILLION)
  • FIG. 14: U.K. MEDICAL IMPLANTS MARKET, (20142022) ($MILLION)
  • FIG. 15: REST OF EUROPE MEDICAL IMPLANTS MARKET, (20142022) ($MILLION)
  • FIG. 16: JAPAN MEDICAL IMPLANTS MARKET, (20142022) ($MILLION)
  • FIG. 17: CHINA MEDICAL IMPLANTS MARKET, (20142022) ($MILLION)
  • FIG. 18: INDIA MEDICAL IMPLANTS MARKET, (20142022) ($MILLION)
  • FIG. 19: REST OF ASIA-PACIFIC MEDICAL IMPLANTS MARKET, (20142022) ($MILLION)
  • FIG. 20: LATIN AMERICA MEDICAL IMPLANTS MARKET, (20142022) ($MILLION)
  • FIG. 21: MIDDLE EAST MEDICAL IMPLANTS MARKET, (20142022) ($MILLION)
  • FIG. 22: AFRICA MEDICAL IMPLANTS MARKET, (20142022) ($MILLION)
  • FIG. 23: ABBOTT: REVENUE, 2013-2015, ($MILLION)
  • FIG. 24: ABBOTT: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
  • FIG. 25: ABBOTT: REVENUE, BY GEOGRAPHY, 2015 (%)
  • FIG. 26: ABBOTT: SWOT ANALYSIS
  • FIG. 27: BIOTRONIK- SWOT ANALYSIS
  • FIG. 28: BOSTON SCIENTIFIC: REVENUE, 20132015 ($MILLION)
  • FIG. 29: BOSTON SCIENTIFIC: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
  • FIG. 30: BOSTON SCIENTIFIC: REVENUE, BY SUBSEGMENT, 2015 (%)
  • FIG. 31: BOSTON SCIENTIFIC: REVENUE, BY GEOGRAPHY, 2015 (%)
  • FIG. 32: BOSTON SCIENTIFIC: SWOT ANALYSIS
  • FIG. 33: C. R. BARD: REVENUE, 20132015 ($MILLION)
  • FIG. 34: C. R. BARD: REVENUE, BY PRODUCT TYPE CATEGORY, 2015 (%)
  • FIG. 35: C. R. BARD: REVENUE, BY GEOGRAPHY, 2015 (%)
  • FIG. 36: C. R. BARD - SWOT ANALYSIS
  • FIG. 37: CARDINAL HEALTH: REVENUE, 20132015 ($MILLION)
  • FIG. 38: CARDINAL HEALTH: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
  • FIG. 39: CARDINAL HEALTH: REVENUE, BY GEOGRAPHY, 2015 (%)
  • FIG. 40: CARDINAL HEALTH: SWOT ANALYSIS
  • FIG. 41: CONMED: REVENUE, 20132015 ($MILLION)
  • FIG. 42: CONMED: REVENUE, BY PRODUCT TYPE CATEGORY, 2015 (%)
  • FIG. 43: CONMED: REVENUE, BY GEOGRAPHY, 2015 (%)
  • FIG. 44: CONMED: SWOT ANALYSIS
  • FIG. 45: GLOBUS MEDICAL: NET SALES, 20132015 ($MILLION)
  • FIG. 46: GLOBUS MEDICAL: REVENUE, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
  • FIG. 47: GLOBUS MEDICAL: REVENUE, BY GEOGRAPHY, 2015 (%)
  • FIG. 48: GLOBUS MEDICAL: SWOT ANALYSIS
  • FIG. 49: INTEGRA LIFESCIENCES: REVENUE, 20132015 ($MILLION)
  • FIG. 50: INTEGRA LIFESCIENCES: REVENUE, BY PRODUCT TYPE CATEGORY, 2015 (%)
  • FIG. 51: INTEGRA LIFESCIENCES: REVENUE, BY GEOGRAPHY, 2015 (%)
  • FIG. 52: INTEGRA LIFESCIENCES - SWOT ANALYSIS
  • FIG. 53: J&J: REVENUE, 20132015 ($MILLION)
  • FIG. 54: J&J: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
  • FIG. 55: J&J: REVENUE, BY GEOGRAPHY, 2015 (%)
  • FIG. 56: J & J: SWOT ANALYSIS
  • FIG. 57: LIVANOVA: NET SALES, 20132015 ($MILLION)
  • FIG. 58: LIVANOVA: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
  • FIG. 59: LIVANOVA: REVENUE, BY GEOGRAPHY, 2015 (%)
  • FIG. 60: LIVANOVA: REVENUE, BY GEOGRAPHY, 2015 (%)
  • FIG. 61: LIVANOVA- SWOT ANALYSIS
  • FIG. 62: MEDTRONIC: NET SALES, 20132015 ($MILLION)
  • FIG. 63: MEDTRONIC: REVENUE, BY SEGMENT, 2015 (%)
  • FIG. 64: MEDTRONIC: CARDIAC AND VASCULAR GROUP REVENUE, BY SUBSEGMENT, 2015 (%)
  • FIG. 65: MEDTRONIC: SWOT ANALYSIS
  • FIG. 66: NUVASIVE: REVENUE, 20132015 ($MILLION)
  • FIG. 67: NUVASIVE: REVENUE, BY PRODUCT TYPE CATEGORY, 2015 (%)
  • FIG. 68: NUVASIVE: REVENUE, BY GEOGRAPHY, 2015 (%)
  • FIG. 69: NUVASIVE: SWOT ANALYSIS
  • FIG. 70: SMITH & NEPHEW: REVENUE, 20132015 ($MILLION)
  • FIG. 71: SMITH & NEPHEW: REVENUE, BY PRODUCT TYPE, 2015 (%)
  • FIG. 72: SMITH & NEPHEW: REVENUE, BY GEOGRAPHY, 2015 (%)
  • FIG. 73: SMITH & NEPHEW: SWOT ANALYSIS
  • FIG. 74: ST. JUDE MEDICAL: NET SALES, 20132015 ($MILLION)
  • FIG. 75: ST. JUDE MEDICAL: REVENUE, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
  • FIG. 76: ST. JUDE MEDICAL: REVENUE, BY GEOGRAPHY, 2015 (%)
  • FIG. 77: ST. JUDE MEDICAL - SWOT ANALYSIS
  • FIG. 78: STRAUMANN: REVENUE, 20132015 ($MILLION)
  • FIG. 79: STRAUMANN: REVENUE, BY GEOGRAPHY, 2015 (%)
  • FIG. 80: STRAUMANN: SWOT ANALYSIS
  • FIG. 81: STRYKER: REVENUE, 20132015 ($MILLION)
  • FIG. 82: STRYKER: REVENUE, BY SEGMENT, 2015 (%)
  • FIG. 83: STRYKER: REVENUE, BY GEOGRAPHY, 2015 (%)
  • FIG. 84: STRYKER - SWOT ANALYSIS
  • FIG. 85: WRIGHT- COMPANY SNAPSHOT
  • FIG. 86: WRIGHT: REVENUE, 20132015 ($MILLION)
  • FIG. 87: WRIGHT: REVENUE, BY PRODUCT TYPE CATEGORY, 2015 (%)
  • FIG. 88: WRIGHT: REVENUE, BY GEOGRAPHY, 2015 (%)
  • FIG. 89: WRIGHT- SWOT ANALYSIS
  • FIG. 90: ZIMMER BIOMET: REVENUE, 20132015 ($MILLION)
  • FIG. 91: ZIMMER BIOMET: REVENUE, BY PRODUCT TYPE CATEGORY, 2015 (%)
  • FIG. 92: ZIMMER BIOMET: REVENUE, BY GEOGRAPHY, 2015 (%)
  • FIG. 93: ZIMMER BIOMET- SWOT ANALYSIS
Back to Top